Sharps Tech Seeks Shareholder Nod for Major Warrant Issuances, New Director

TL;DR

**Sharps Technology is asking shareholders to greenlight massive dilution, which could be a necessary evil for growth or a red flag for existing equity holders.**

AI Summary

Sharps Technology Inc. (STSSW) is holding a Special Meeting of Stockholders on October 14, 2025, to address critical governance and financing matters. The company seeks to elect Annemarie Tierney as a director until the 2026 annual meeting. Crucially, stockholders will vote on two proposals to approve significant common stock issuances under Nasdaq Listing Rule 5635(a): 49,673,120 shares for the exercise of pre-funded and stapled cryptocurrency warrants, and 6,321,367 shares for the exercise of warrants issued to Sol Markets, a strategic advisor. These issuances total 55,994,487 shares, representing a substantial potential dilution compared to the 26,600,848 shares outstanding on the September 16, 2025 Record Date. The Board unanimously recommends a 'FOR' vote on all proposals, including an adjournment proposal, emphasizing these actions are in the best interests of the Company and its stockholders.

Why It Matters

These proposals are critical for Sharps Technology Inc. as they directly impact the company's capital structure and future strategic flexibility. The potential issuance of 55,994,487 new shares, significantly more than the 26,600,848 shares currently outstanding, could lead to substantial dilution for existing investors, affecting per-share earnings and voting power. For employees and customers, successful warrant exercises could signal strengthened financial health and support ongoing operations or new initiatives. In a competitive market, securing these financing mechanisms is vital for Sharps Technology to fund its business and maintain its strategic direction, especially given the involvement of a 'Strategic Advisor' like Sol Markets.

Risk Assessment

Risk Level: high — The risk level is high due to the potential for significant shareholder dilution. The company is seeking approval to issue 49,673,120 shares for cryptocurrency warrants and an additional 6,321,367 shares for strategic advisor warrants, totaling 55,994,487 new shares. This compares to only 26,600,848 shares of common stock outstanding as of the September 16, 2025 Record Date, representing a potential increase of over 210% in outstanding shares.

Analyst Insight

Investors should carefully evaluate the potential dilution from the proposed warrant exercises against the company's strategic rationale for these issuances. Consider voting 'AGAINST' the warrant proposals if you believe the dilution outweighs the benefits, or 'FOR' if you trust the Board's assessment that this capital is essential for future growth and operations.

Key Numbers

• 49,673,120 — Shares for Cryptocurrency Warrants (Potential issuance upon exercise of pre-funded and stapled warrants)
• 6,321,367 — Shares for Strategic Advisor Warrants (Potential issuance upon exercise of warrants to Sol Markets)
• 26,600,848 — Shares Outstanding (Common stock issued and outstanding on September 16, 2025 Record Date)
• October 14, 2025 — Special Meeting Date (Date of the virtual Special Meeting of Stockholders)
• September 16, 2025 — Record Date (Date for determining stockholders entitled to vote)
• 10:00 A.M. Eastern Time — Meeting Time (Start time for the virtual Special Meeting)

Key Players & Entities

• Sharps Technology Inc. (company) — Registrant and issuer of common stock
• Annemarie Tierney (person) — Nominee for director
• Nasdaq Listing Rule 5635(a) (regulator) — Rule requiring shareholder approval for certain issuances
• Sol Markets (company) — Cayman Islands exempt company, Strategic Advisor
• Paul K. Danner (person) — Principal Executive Officer and proxy appointee
• Yuwen (Alice) Zhang (person) — Proxy appointee
• Andrew R. Crescenzo (person) — Chief Financial Officer and proxy appointee
• VStock Transfer LLC (company) — Transfer agent
• Securities and Exchange Commission (regulator) — Regulatory body for proxy statements

FAQ

Industry Context

Sharps Technology Inc. operates in a sector that involves specialized medical device components and potentially related financial instruments. The company's reliance on warrant exercises for financing suggests a strategy common in early-stage or growth-oriented companies seeking capital. The broader medical technology industry is characterized by innovation, regulatory hurdles, and competitive pressures for market share.

Regulatory Implications

The proposed stock issuances require shareholder approval under Nasdaq Listing Rule 5635(a), indicating a potential for significant dilution that necessitates transparency and investor consent. Failure to obtain approval could impact the company's ability to raise capital and maintain its Nasdaq listing. Compliance with SEC regulations for proxy solicitations and disclosures is paramount.

What Investors Should Do

1. Review the proposed stock issuances carefully.
2. Vote 'FOR' all proposals, including the director election and stock issuances.
3. Attend the virtual Special Meeting or submit a proxy.

Key Dates

• 2025-10-14: Special Meeting of Stockholders — Stockholders will vote on critical governance and financing matters, including significant stock issuances and director election.
• 2025-09-16: Record Date — Determines which stockholders are entitled to vote at the Special Meeting.
• 2025-09-23: Distribution of Proxy Materials — Stockholders will begin receiving proxy materials and the 2024 annual report.
• 2024-12-31: Fiscal Year End — The financial statements for this period are included in the 2024 annual report on Form 10-K.

Glossary

DEF 14A

A proxy statement filed with the SEC by publicly traded companies to solicit shareholder votes. (This document outlines the proposals to be voted on at the Special Meeting and provides background information.)

Pre-funded and stapled cryptocurrency warrants

Financial instruments that give the holder the right to purchase shares, often with specific conditions related to cryptocurrency or pre-funding arrangements. (The exercise of these warrants will result in a significant issuance of new shares, potentially diluting existing shareholders.)

Sol Markets

A strategic advisor to Sharps Technology, Inc. (Warrants issued to Sol Markets are being exercised, requiring a shareholder vote for the associated stock issuance.)

Nasdaq Listing Rule 5635(a)

A rule requiring shareholder approval for the issuance of securities in certain circumstances, typically when the issuance exceeds 20% of the outstanding common stock. (The company is seeking shareholder approval under this rule for the proposed stock issuances due to their significant dilutive impact.)

Common Stock

The basic form of ownership in a corporation, representing a claim on the company's assets and earnings. (The proposed stock issuances will increase the number of outstanding common shares.)

Proxy

A document that authorizes another person to act on behalf of a shareholder, typically to vote their shares. (Shareholders are being asked to grant a proxy to vote on the proposals at the Special Meeting.)

Year-Over-Year Comparison

This filing is a proxy statement for a special meeting, not an annual report comparing year-over-year financial performance. Therefore, a direct comparison of key metrics like revenue growth or margin changes to a previous filing is not possible from this document alone. The primary focus is on upcoming shareholder votes regarding significant stock issuances and governance changes, rather than a review of past financial results.

Key Financial Figures

• $0.0001 — holders of our common stock, par value $0.0001 per share (the “Common Stock&rdqu

Filing Documents

• formdef14a.htm (DEF 14A) — 354KB
• proxy_001.jpg (GRAPHIC) — 828KB
• proxy_002.jpg (GRAPHIC) — 511KB
• 0001493152-25-014624.txt ( ) — 2199KB

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 21 Other Matters 22 Where You Can Find More Information 22 SHARPS TECHNOLOGY, INC. 105 Maxess Road Suite 124 Melville, NY 11747 Telephone: (631) 574-4436 PROXY 2025 SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON OCTOBER 14, 2025 Unless the context otherwise requires, references in this proxy statement to “we,” “us,” “our,” the “Company” or “Sharps” refer to Sharps Technology, Inc., a Nevada corporation and its consolidated subsidiaries as a whole. In addition, unless the context otherwise requires, references to “stockholders” are to the holders of our common stock, par value $0.0001 per share (the “Common Stock”). The accompanying proxy is solicited by the board of directors of the Company (the “Board”) on behalf of Sharps Technology, Inc. to be voted at the Company’s 2025 Special Meeting of Stockholders (the “Special Meeting”) to be held on Tuesday, October 14, 2025, and at any adjournment, continuation or postponement thereof. The Special Meeting will be held virtually via a live webcast on the Internet on Tuesday, October 14, 2025, at 10:00 A.M., Eastern Time. If you held shares of our Common Stock at the close of business on September 16, 2025 (the “Record Date”), you are invited to attend the Special Meeting virtually at www.virtualshareholdermeeting.com/STSS2025SM2 and if you held shares of our Common Stock at the close of business on the Record Date, you are invited to vote on the proposals described in this proxy statement. On or about September 23, 2025, we intend to begin sending to our stockholders entitled to vote the proxy materials containing instructions on how to access our proxy statement for the Special Meeting and our 2024 annual report on Form 10-K. This proxy statement, the notice of the Sp

View Full Filing

View this DEF 14A filing on SEC EDGAR